Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

BACKGROUND: In lung clinical trials with imaging, blinded independent central review with double reads is recommended to reduce evaluation bias and the Response Evaluation Criteria In Solid Tumor (RECIST) is still widely used. We retrospectively analyzed the inter-reader discrepancies rate over time...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaumont, Hubert, Iannessi, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585359/
https://www.ncbi.nlm.nih.gov/pubmed/37869080
http://dx.doi.org/10.3389/fonc.2023.1239570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585359/
https://www.ncbi.nlm.nih.gov/pubmed/37869080
http://dx.doi.org/10.3389/fonc.2023.1239570

Ejemplares similares